|
|
||||||||
1From the Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and the 2Department of Ophthalmology, Dokkyo University School of Medicine, Tochigi, Japan.
PURPOSE. To determine whether antisense downregulation of p27kip1 will overcome G1-phase arrest and promote cell cycle progression in rat corneal endothelial cells (CECs).
METHODS. Confluent cultures of rat CECs were incubated for 24 hours in the presence of p27kip1 antisense (AS) oligonucleotides (oligoS) using nonliposomal lipid transfection. Control cultures were incubated under one of the following conditions: no oligos or lipid-containing buffer, lipid-containing buffer alone, or lipid-containing buffer plus missense (MS) p27kip1 oligo. Viability was tested by a cell-viability assay after 0, 24, 48, and 72 hours. After postincubation for 0, 24, 48, or 72 hours, cultures were fixed and immunostained for p27kip1, to test for downregulation, or for Ki67 or BrdU, to detect actively cycling cells. Western blot and immunocytochemistry (ICC) studies were conducted to determine the effect of p27kip1 antisense treatment on the relative protein level and subcellular localization of several cell cycle proteins, including cyclin-D1, -E, -A, and -B1; CDK2 and -4; p21cip1; and p15INK4b. Proliferation was determined by direct counting of propidium iodide (PI) or 4',6'-diamino-2-phenylindole (DAPI)-stained cells.
RESULTS. Viability was not significantly affected by lipid-based oligo transfection for up to 48 hours, after which a decline was noted. The protein level of p27kip1 was reduced after AS transfection in a time-dependent manner. Nuclear staining for p27kip1 was greatly reduced in CECs incubated with AS oligo. No change in p27kip1 levels was observed in controls at any time point tested. p27kip1 AS oligo transfection increased cyclin-D1, -E, -A, and -B1 protein levels, and all cyclins were localized to the nucleus. No changes in protein level were observed for CDK2, CDK4, p21cip1, or p15INK4B. A time-dependent increase in the relative number of Ki67- and BrdU-positive cells was noted in CECs incubated with AS oligo. In contrast, no to few Ki67- or BrdU-positive cells were observed in CECs incubated with MS oligo or the buffer-treated control cells. The percentage increase in the number of cells transfected with AS oligo increased with time, compared with that of cells transfected with MS oligo.
CONCLUSIONS. Treatment with p27kip1 antisense oligonucleotides followed by postincubation in 10% FBS lowers endogenous p27kip1 protein levels and promotes proliferation in confluent cultures of rat CECs.
This article has been cited by other articles:
![]() |
Y. Nakano, M. Oyamada, P. Dai, T. Nakagami, S. Kinoshita, and T. Takamatsu Connexin43 Knockdown Accelerates Wound Healing but Inhibits Mesenchymal Transition after Corneal Endothelial Injury In Vivo Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 93 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Lee and E. P. Kay Involvement of Two Distinct Ubiquitin E3 Ligase Systems for p27 Degradation in Corneal Endothelial Cells Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Suh, C. Zhang, R. S. Chuck, W. J. Stark, S. Naylor, K. Binley, S. Chakravarti, and A. S. Jun Cryopreservation and Lentiviral-Mediated Genetic Modification of Human Primary Cultured Corneal Endothelial Cells Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3056 - 3061. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kikuchi, C. Zhu, T. Senoo, Y. Obara, and N. C. Joyce p27kip1 siRNA Induces Proliferation in Corneal Endothelial Cells from Young but Not Older Donors Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4803 - 4809. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Enomoto, T. Mimura, D. L. Harris, and N. C. Joyce Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4330 - 4340. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |